| Title |
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human GliomaMechanisms of Resistance in BRAFV600E-Mutant Glioma
|
|---|---|
| Published in |
Clinical Cancer Research, August 2021
|
| DOI | 10.1158/1078-0432.ccr-21-2660 |
| Pubmed ID | |
| Authors |
Karisa C. Schreck, Andrew Morin, Guisheng Zhao, Amy N. Allen, Patrick Flannery, Michael Glantz, Adam L. Green, Chris Jones, Kenneth L. Jones, Lindsay B. Kilburn, Kellie J. Nazemi, David Samuel, Bridget Sanford, David A. Solomon, Jiawan Wang, Christine A. Pratilas, Theodore Nicolaides, Jean M. Mulcahy Levy |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 41% |
| France | 2 | 9% |
| Italy | 1 | 5% |
| Australia | 1 | 5% |
| Canada | 1 | 5% |
| Portugal | 1 | 5% |
| Unknown | 7 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 73% |
| Scientists | 4 | 18% |
| Practitioners (doctors, other healthcare professionals) | 1 | 5% |
| Unknown | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 16 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 3 | 19% |
| Unspecified | 1 | 6% |
| Student > Bachelor | 1 | 6% |
| Student > Ph. D. Student | 1 | 6% |
| Researcher | 1 | 6% |
| Other | 2 | 13% |
| Unknown | 7 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 19% |
| Biochemistry, Genetics and Molecular Biology | 3 | 19% |
| Unspecified | 1 | 6% |
| Neuroscience | 1 | 6% |
| Agricultural and Biological Sciences | 1 | 6% |
| Other | 0 | 0% |
| Unknown | 7 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2022.
All research outputs
#738,135
of 24,701,594 outputs
Outputs from Clinical Cancer Research
#471
of 13,084 outputs
Outputs of similar age
#17,732
of 421,989 outputs
Outputs of similar age from Clinical Cancer Research
#13
of 137 outputs
Altmetric has tracked 24,701,594 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,084 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,989 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 137 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.